G. Schumock

Publications220
h-index35
Citations4,933
Highly Influential Citations170
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • K. Suda
  • 166 Publications, 4,049 Citations
  • R. Hunkler
  • 37 Publications, 1,683 Citations
  • T. Lee
  • 254 Publications, 6,642 Citations
  • L. Vermeulen
  • 99 Publications, 2,811 Citations
  • Publications
  • Influence
Focusing on the preventability of adverse drug reactions.
  • 447
  • 19
Pure red-cell aplasia and epoetin therapy.
BACKGROUND Between 1988 and 1998, antibody-associated pure red-cell aplasia was reported in three patients who had undergone treatment with recombinant human erythropoietin (epoetin). Between 1998… Expand
  • 398
  • 16
  • PDF
The financial burden of cancer: estimates from a study of insured women with breast cancer.
The financial impact of cancer can be large, even among persons with comprehensive health insurance policies. Prior studies have found that women with cancer are especially likely to suffer financial… Expand
  • 166
  • 9
Factors that Influence Prescribing Decisions
BACKGROUND Strategies to control the quality and cost of medication use are largely dependent on the ability to alter selection of medications. Previous models of prescribing behavior have focused on… Expand
  • 101
  • 7
National trends in prescription drug expenditures and projections for 2017.
PURPOSE Historical trends and factors likely to influence future pharmaceutical expenditures are discussed, and projections are made for drug spending in 2017 in nonfederal hospitals, clinics, and… Expand
  • 41
  • 7
  • PDF
Guidelines for Acute Decompensated Heart Failure Treatment
OBJECTIVE To describe the development of guidelines for the treatment of acute decompensated heart failure (ADHF) in the emergency department/observation unit (ED-OU) setting for hospitals that are… Expand
  • 82
  • 6
Prioritizing Future Research on Off‐Label Prescribing: Results of a Quantitative Evaluation
Study Objective. To develop a prioritized list of individual drugs for which future research regarding off‐label uses is warranted.
  • 100
  • 6
Evidence of the Economic Benefit of Clinical Pharmacy Services: 1996–2000
We sought to summarize and assess original evaluations of the economic impact of clinical pharmacy services published from 1996–2000, and to provide recommendations and methodologic considerations… Expand
  • 266
  • 5
  • PDF
The Research on Adverse Drug Events and Reports (RADAR) project.
CONTEXT In 1998, a multidisciplinary team of investigators initiated RADAR (Research on Adverse Drug events And Reports), a clinically based postmarketing surveillance program that systematically… Expand
  • 138
  • 5
  • PDF
Economic Evaluations of Clinical Pharmacy Services: 2001–2005
The objectives of this review were to summarize and evaluate studies that measured the economic impact of clinical pharmacy services published between 2001 and 2005 (inclusive) and to provide… Expand
  • 115
  • 5